Evidence map›Paper›PMID 30174424›Full record

ArticleInternational journal of nanomedicine2018

In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application.

Mohammad Amrollahi-Sharifabadi, Mohammad Kazem Koohi, Ehsan Zayerzadeh, Mohammad Hassan Hablolvarid, Jalal Hassan, Alexander M Seifalian

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Flexible and Stretchable Bioelectronics.Materials (Basel, Switzerland) · 2022
    Review
  18. Article
  19. Hepatotoxicity of graphene oxide in Wistar rats.Environmental science and pollution research international · 2021
    Article
  20. Graphene Oxide: Opportunities and Challenges in Biomedicine.Nanomaterials (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mohammad Amrollahi-SharifabadiDepartment of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran, mkkoohi@ut.ac.ir.
Mohammad Kazem KoohiDepartment of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran, mkkoohi@ut.ac.ir.
Ehsan ZayerzadehDepartment of Biology, Faculty of Food Industry and Agriculture, Standard Research Institute, Karaj, Iran.
Mohammad Hassan HablolvaridDepartment of Pathology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Jalal HassanDepartment of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran, mkkoohi@ut.ac.ir.
Alexander M SeifalianNanoRegMed ltd, Nanotechnology and Regenerative Medicine Commercialization Centre, The London Bioscience Innovation Centre, London, UK.
University of Tehran · IRLondon Centre for Nanotechnology · GBRazi Vaccine and Serum Research Institute · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGraphene is considered as a wonder material; it is the strongest material on the planet, super-elastic, and conductive. Its application in biomedicine is huge, with a multibillion-dollar industry, and will revolutionize the diagnostic and treatment of diseases. However, its safety and potential toxicity is the main challenge.

methodsThis study assessed the potential toxicity of graphene oxide nanoplatelets (GONs) in an in vivo animal model using systemic, hematological, biochemical, and histopathological examinations. Normal saline (control group) or GONs (3-6 layers, lateral dimension=5-10 μm, and thickness=0.8-2 nm) at dose rate of 50, 150, or 500 mg/kg were intraperitoneally injected into adult male Wistar rats (n=5) every 48 hours during 1 week to receive each animal a total of four doses. The animals were allowed 2 weeks to recover after the last dosing. Then, animals were killed and the blood was collected for hematological and biochemical analysis. The organs including the liver, kidney, spleen, lung, intestine, brain, and heart were harvested for histopathological evaluations.

resultsThe results showed GONs prevented body weight gain in animals after 21 days, treated at 500 mg/kg, but not in the animals treated at 150 or 50 mg/kg GONs. The biochemical analysis showed a significant increase in total bilirubin, with a significant decrease in triglycerides and high-density lipoprotein in animals treated at 500 mg/kg. Nonetheless, other hematological and biochemical parameters remained statistically insignificant in all GONs treated animals. The most common histopathological findings in the visceral organs were granulomatous reaction with giant cell formation and accumulation of GONs in capsular regions. Also, small foci of neuronal degeneration and necrosis were the most outstanding findings in the brain, including the cerebellum.

conclusionIn conclusion, this study shows that GONs without functionalization are toxic. The future study is a comparison of the functionalized with non-functionalized GONs.

Indexed as

Toxicity TestsAnimalsBody WeightGraphiteInjectionsMaleNanoparticlesOrgan SpecificityRats, WistarSpectrum Analysis, RamanX-Ray DiffractionGraphitegraphene oxidehistopathologynanoplateletsnanotechnologypreclinicalrattoxicity

Identifiers

PMID30174424
PMCPMC6110298
OpenAlexW2887996639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.